| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3577848
Max Phase: Preclinical
Molecular Formula: C4H12O6P2
Molecular Weight: 218.08
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COP(=O)(O)CP(=O)(OC)OC
Standard InChI: InChI=1S/C4H12O6P2/c1-8-11(5,6)4-12(7,9-2)10-3/h4H2,1-3H3,(H,5,6)
Standard InChI Key: LEUZCNJMZSRWGQ-UHFFFAOYSA-N
Associated Targets(Human)
Hydroxyapatite 165 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 218.08 | Molecular Weight (Monoisotopic): 218.0109 | AlogP: 1.26 | #Rotatable Bonds: 5 |
| Polar Surface Area: 82.06 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 1.72 | CX Basic pKa: | CX LogP: -0.71 | CX LogD: -3.02 |
| Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.70 | Np Likeness Score: 0.24 |
References
| 1. Puljula E, Turhanen P, Vepsäläinen J, Monteil M, Lecouvey M, Weisell J.. (2015) Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters., 6 (4): [PMID:25893039] [10.1021/ml5004603] |
Source
Source(1):